# Hikma Injectables USA Inc – FDA Inspection, Jun 8, 2022

Source: https://www.keypedia.com/records/fda_inspections/hikma-injectables-usa-inc/52afa7fb-d01b-4c13-8b57-fd998b42151e
Source feed: FDA_Inspections

> FDA inspection 1171399 of Hikma Injectables USA Inc, June 08, 2022. Classification: Voluntary Action Indicated (VAI). 3 citations under 21 CFR part 211. 2 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1171399
- Company Name: Hikma Injectables USA Inc
- Inspection Date: 2022-06-08
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 3

## Related Documents

- [FDA Inspection 1278072 - 2025-08-08](https://www.keypedia.com/records/fda_inspections/hikma-injectables-usa-inc/e0a7f487-fa21-4b60-bc86-8829952f8a20)
- [FDA Inspection 1242194 - 2024-06-25](https://www.keypedia.com/records/fda_inspections/hikma-injectables-usa-inc/3dd0cd11-74b8-45d9-8683-ef9412101910)

Company: https://www.keypedia.com/companies/hikma-injectables-usa-inc/9d594ef4-e334-4c2d-a6ed-90845b8c29df

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c